Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Temozolomide × 30 days × Clear all

Sponsor

Conditions

Glioblastoma 22 Glioma 12 Sarcoma, Ewing 7 Brain Neoplasms 7 Gliosarcoma 6 Astrocytoma 6 Sarcoma 4 Rhabdomyosarcoma 4 Recurrence 3 Osteosarcoma 3 Neuroblastoma 3 Neoplasm Metastasis 3 Medulloblastoma 3 Ependymoma 3 Diffuse Intrinsic Pontine Glioma 3 Small Cell Lung Carcinoma 2 Lymphoma, Follicular 2 Lymphoma 2 Desmoplastic Small Round Cell Tumor 2 Colorectal Neoplasms 2 Wilms Tumor 1 Somatostatinoma 1 Rhabdoid Tumor 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive, Peripheral 1

Interventions

trametinib 1 pralsetinib 1 ponatinib 1 pembrolizumab 1 fludarabine phosphate 1 fludarabine 1 durvalumab 1 dabrafenib 1 Whole-Body Irradiation 1 Tacrolimus 1 Peripheral Blood Stem Cell Transplantation 1 Pemetrexed 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Immunotherapy 1 Gemcitabine 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Busulfan 1 Bone Marrow Transplantation 1 Biopsy 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡